Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (10): 975-984.DOI: 10.3969/j.issn.1673-8640.2024.10.009
Previous Articles Next Articles
ZHANG Shiqiu, LÜ Jie, YU Rong, WANG Chuanling, LIN Ziyan, ZHU Yongjun()
Received:
2023-10-15
Revised:
2024-06-22
Online:
2024-10-30
Published:
2024-11-08
CLC Number:
ZHANG Shiqiu, LÜ Jie, YU Rong, WANG Chuanling, LIN Ziyan, ZHU Yongjun. Screening and preliminary verification of differentially expressed genes related to chronic kidney disease based on GEO database[J]. Laboratory Medicine, 2024, 39(10): 975-984.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.10.009
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
---|---|---|
HSP90AA1 | GGTACCCTACGGGGAGCG | GTTAACAGGTGCCCTGCTTCTCA |
IGF1 | AGAGCCTGCGCAATGGAATA | TGGTGTGCATCTTCACCTTCA |
REN | CAAGTGCAGCCGTCTCTACA | TGATTCCACCCACGGTGATG |
MMP2 | GGACTTAGACCGCTTGGCTT | GTGTTCAGGTATTGCATGTGCT |
ACTA2 | GCCTGAGGGAAGGTCCTAAC | CTTCACAGGATTCCCGTCTT |
PXN | TCCCTGCCATCACTGTGAAC | CAGGCCCTGGATCTTGAAAT |
COL3A1 | TAAAGGCGAAATGGGTCCCG | GGCACCATTCTTACCAGGCT |
CALCA | AGATCCTGGCTCAGAGAGGT | GCACATAGTCCTGCACCAGT |
DMD | ACAGCTGGCATGGAAGATGAA | TTCGAGGAGGTCTAGGAGGC |
LAMA2 | CTTGAGTATGAAAGCAAGGCCAG | AGAGCTCCACAAAACCAGGC |
β-actin | ACAGAGCCTCGCCTTTGCC | GATATCATCATCCATGGTGAGCTGG |
hsa-let-7b-5p | GCGCGTGAGGTAGTAGGTTGT | AGTGCAGGGTCCGAGGTATT |
hsa-miR-29a-3p | CGCGTAGCACCATCTGAAAT | AGTGCAGGGTCCGAGGTATT |
hsa-miR-29b-3p | CGCGTAGCACCATTTGAAATC | AGTGCAGGGTCCGAGGTATT |
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
hsa-miR-335-5p | CGCGTCAAGAGCAATAACGAA | AGTGCAGGGTCCGAGGTATT |
hsa-miR-421 | GCGCGATCAACAGACATTAATT | AGTGCAGGGTCCGAGGTATT |
U6 | CAAATTCGTGAAGCGTTCCA | AGTGCAGGGTCCGAGGTATT |
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
---|---|---|
HSP90AA1 | GGTACCCTACGGGGAGCG | GTTAACAGGTGCCCTGCTTCTCA |
IGF1 | AGAGCCTGCGCAATGGAATA | TGGTGTGCATCTTCACCTTCA |
REN | CAAGTGCAGCCGTCTCTACA | TGATTCCACCCACGGTGATG |
MMP2 | GGACTTAGACCGCTTGGCTT | GTGTTCAGGTATTGCATGTGCT |
ACTA2 | GCCTGAGGGAAGGTCCTAAC | CTTCACAGGATTCCCGTCTT |
PXN | TCCCTGCCATCACTGTGAAC | CAGGCCCTGGATCTTGAAAT |
COL3A1 | TAAAGGCGAAATGGGTCCCG | GGCACCATTCTTACCAGGCT |
CALCA | AGATCCTGGCTCAGAGAGGT | GCACATAGTCCTGCACCAGT |
DMD | ACAGCTGGCATGGAAGATGAA | TTCGAGGAGGTCTAGGAGGC |
LAMA2 | CTTGAGTATGAAAGCAAGGCCAG | AGAGCTCCACAAAACCAGGC |
β-actin | ACAGAGCCTCGCCTTTGCC | GATATCATCATCCATGGTGAGCTGG |
hsa-let-7b-5p | GCGCGTGAGGTAGTAGGTTGT | AGTGCAGGGTCCGAGGTATT |
hsa-miR-29a-3p | CGCGTAGCACCATCTGAAAT | AGTGCAGGGTCCGAGGTATT |
hsa-miR-29b-3p | CGCGTAGCACCATTTGAAATC | AGTGCAGGGTCCGAGGTATT |
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
hsa-miR-335-5p | CGCGTCAAGAGCAATAACGAA | AGTGCAGGGTCCGAGGTATT |
hsa-miR-421 | GCGCGATCAACAGACATTAATT | AGTGCAGGGTCCGAGGTATT |
U6 | CAAATTCGTGAAGCGTTCCA | AGTGCAGGGTCCGAGGTATT |
排序 | 基因 | 编码蛋白 | 评分/分 |
---|---|---|---|
1 | HSP90AA1 | 热休克蛋白90α家族A类成员1 | 16 |
1 | IGF1 | 类胰岛素一号增长因子 | 16 |
3 | REN | 肾素 | 14 |
3 | MMP2 | 基质金属蛋白酶-2 | 14 |
5 | ACTA2 | 肌动蛋白α2,平滑肌 | 11 |
5 | PXN | 桩蛋白 | 11 |
5 | COL3A1 | Ⅲ型胶原蛋白 alpha 1 链 | 11 |
8 | CALCA | 降钙素相关多肽α | 10 |
9 | DMD | 肌营养不良蛋白 | 9 |
9 | LAMA2 | 层黏连蛋白亚基α 2 | 9 |
排序 | 基因 | 编码蛋白 | 评分/分 |
---|---|---|---|
1 | HSP90AA1 | 热休克蛋白90α家族A类成员1 | 16 |
1 | IGF1 | 类胰岛素一号增长因子 | 16 |
3 | REN | 肾素 | 14 |
3 | MMP2 | 基质金属蛋白酶-2 | 14 |
5 | ACTA2 | 肌动蛋白α2,平滑肌 | 11 |
5 | PXN | 桩蛋白 | 11 |
5 | COL3A1 | Ⅲ型胶原蛋白 alpha 1 链 | 11 |
8 | CALCA | 降钙素相关多肽α | 10 |
9 | DMD | 肌营养不良蛋白 | 9 |
9 | LAMA2 | 层黏连蛋白亚基α 2 | 9 |
微小RNA名称 | degree值 | 相互作用的基因 | 中介中心性 |
---|---|---|---|
hsa-miR-29a-3p | 4 | COL3A1、IGF1、MMP2、LAMA2 | 2 463.16 |
hsa-miR-335-5p | 3 | COL3A1、MMP2、PXN | 4 229.57 |
hsa-let-7b-5p | 3 | COL3A1、DMD、HSP90AA1 | 2 971.08 |
hsa-miR-29b-3p | 3 | COL3A1、MMP2、LAMA2 | 217.37 |
hsa-miR-421 | 2 | HSP90AA1、IGF1 | 4 480.20 |
微小RNA名称 | degree值 | 相互作用的基因 | 中介中心性 |
---|---|---|---|
hsa-miR-29a-3p | 4 | COL3A1、IGF1、MMP2、LAMA2 | 2 463.16 |
hsa-miR-335-5p | 3 | COL3A1、MMP2、PXN | 4 229.57 |
hsa-let-7b-5p | 3 | COL3A1、DMD、HSP90AA1 | 2 971.08 |
hsa-miR-29b-3p | 3 | COL3A1、MMP2、LAMA2 | 217.37 |
hsa-miR-421 | 2 | HSP90AA1、IGF1 | 4 480.20 |
[1] |
ROMAGNANI P, REMUZZI G, GLASSOCK R, et al. Chronic kidney disease[J]. Nat Rev Dis Primers, 2017, 3:17088.
DOI PMID |
[2] |
谢晖, 沈瀚. 慢性肾脏病患者凝血功能变化及高凝状态影响因素分析[J]. 检验医学, 2021, 36(5):500-503.
DOI |
[3] | KDIGO Conference Participants. Genetics in chronic kidney disease:conclusions from a kidney disease:improving global outcomes(KDIGO) controversies conference[J]. Kidney Int, 2022, 101(6):1126-1141. |
[4] | 朱永俊, 俞容, 李晓燕, 等. Ang Ⅱ联合TNF-α促使肾小管上皮HK-2细胞发生程序性坏死[J]. 中国病理生理杂志, 2021, 37(6):1084-1090. |
[5] | MÉNDEZ-GARCÍA L A, TREJO-MILLÁN F, MARTÍNEZ-REYES C P, et al. Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro[J]. Scand J Immunol, 2018, 88(5):e12716. |
[6] | ZHU Q, SCHERER P E. Immunologic and endocrine functions of adipose tissue:implications for kidney disease[J]. Nat Rev Nephrol, 2018, 14(2):105-120. |
[7] | GRANGE C, BUSSOLATI B. Extracellular vesicles in kidney disease[J]. Nat Rev Nephrol, 2022, 18(8):499-513. |
[8] | SHEN A R, ZHONG X, TANG T T, et al. Integrin,exosome and kidney disease[J]. Front Physiol, 2021, 11:627800. |
[9] |
FEITENG C, LEI C, DENG L, et al. Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/β-catenin signaling pathway[J]. Ren Fail, 2022, 44(1):513-524.
DOI PMID |
[10] | ZHAO W M, WANG Z J, SHI R, et al. Analysis of the potential biological mechanisms of diosmin against renal fibrosis based on network pharmacology and molecular docking approach[J]. BMC Complement Med Ther, 2023, 23(1):157. |
[11] | GUREVICH E, SEGEV Y, LANDAU D. Growth hormone and IGF1 actions in kidney development and function[J]. Cells, 2021, 10(12):3371. |
[12] |
RAMANATHAN G, ELUMALAI R, PERIYASAMY S, et al. Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD[J]. J Biomed Sci, 2016, 23:1.
DOI PMID |
[13] |
CHENG Z, ZHANG X, ZHANG Y, et al. Role of MMP-2 and CD147 in kidney fibrosis[J]. Open Life Sci, 2022, 17(1):1182-1190.
DOI PMID |
[14] | GERRITS T, BROUWER I J, DIJKSTRA K L, et al. Endoglin is an important mediator in the final common pathway of chronic kidney disease to end-stage renal disease[J]. Int J Mol Sci, 2022, 24(1):646. |
[15] | WEI J, XU Z, YAN X. The role of the macrophage-to-myofibroblast transition in renal fibrosis[J]. Front Immunol, 2022, 13:934377. |
[16] | NOH K, BACH D H, CHOI H J, et al. The hidden role of paxillin:localization to nucleus promotes tumor angiogenesis[J]. Oncogene, 2021, 40(2):384-395. |
[17] | 甄永占, 胡刚, 章广玲, 等. 赖氨大黄酸对快速老化小鼠SAMP 10肾组织COL1A1、COL3A1和COL4A1表达的影响[J]. 第三军医大学学报, 2013, 35(17):1805-1808. |
[18] | 郑君芙, 邢淑丽, 宋瑞芬, 等. 降钙素基因相关肽与肾脏疾病[J]. 辽宁中医学院学报, 2006, 8(3):127-128. |
[19] | VIJAYAN P, HACK S, YAO T, et al. LAMA2 and LOXL4 are candidate FSGS genes[J]. BMC Nephrol, 2021, 22(1):320. |
[20] | DALGAARD L T, SØRENSEN A E, HARDIKAR A A, et al. The microRNA-29 family:role in metabolism and metabolic disease[J]. Am J Physiol Cell Physiol, 2022, 323(2):C367-C377. |
[21] | TROJANOWICZ B, IMDAHL T, ULRICH C, et al. Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease[J]. Nephron, 2019, 141(1):61-74. |
[22] | ZHU Y, CUI H, LV J, et al. Angiotensin Ⅱ triggers RIPK3-MLKL-mediated necroptosis by activating the Fas/FasL signaling pathway in renal tubular cells[J]. PLoS One, 2020, 15(3):e0228385. |
[23] | ZHU Y, CUI H, LV J, et al. AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin Ⅱ-infused renal injury mice[J]. Sci Rep, 2019, 9(1):19450. |
[24] | LIN Z, CHEN A, CUI H, et al. Renal tubular epithelial cell necroptosis promotes tubulointerstitial fibrosis in patients with chronic kidney disease[J]. FASEB J, 2022, 36(12):e22625. |
[1] | LIU Ruishan, LONG Fengming, ZOU Chengli. Role of serum exosomal miR-93-5p determination in children with bronchial asthma [J]. Laboratory Medicine, 2024, 39(5): 449-453. |
[2] | ZHANG Miaomiao, DUAN Dongkui, YU Chun, WANG Lina. Expression and prognostic assessment value of miR-924 and SLC1A5 in lung cancer tissues [J]. Laboratory Medicine, 2024, 39(1): 13-18. |
[3] | DAI Hongjian, CUI Haining, LI Yanfeng, CUI Hongmei. Promoting effect of miR-155-5p targeting ARID2 on oral squamous cell carcinoma [J]. Laboratory Medicine, 2024, 39(1): 87-94. |
[4] | LI Liangshan, ZHAO Hu, WANG Shiwen. Screening potential prognostic biomarkers of colorectal cancer based on weighted gene co-expression network analysis [J]. Laboratory Medicine, 2023, 38(9): 825-832. |
[5] | CHEN Wenju, ZHOU Yong, XU Jiajia, WANG Pan. Role of serum exosomal miR-23b-3p and miR-4429 in patients with hepatocellular carcinoma [J]. Laboratory Medicine, 2023, 38(7): 624-628. |
[6] | PAN Xin, LÜ Ying, LI Yang, LI Rongguo. Effects of miR-24-3p targeting CHD5 on migration,invasion and radiosensitivity of thyroid cancer cells [J]. Laboratory Medicine, 2023, 38(7): 640-646. |
[7] | WANG Tengfei, CHEN Shan, AN Hebing, ZHOU Lei. Expressions and roles of lncRNA CRNDE and miR-384 in peripheral blood of patients with acute leukemia [J]. Laboratory Medicine, 2023, 38(7): 686-691. |
[8] | ZHANG Ying, JING Lijuan, LI Li. Relationship between the expression of miR-138 in peripheral blood mononuclear cells of hepatitis B virus proliferation in carriers [J]. Laboratory Medicine, 2023, 38(6): 559-562. |
[9] | ZHAO Jing, WANG Pei, LU Dandan, QI Dandan, LI Xuan. Expression levels of serum miR-4443 and TRAF4 in patients with hemorrhagic stroke [J]. Laboratory Medicine, 2023, 38(5): 413-418. |
[10] | LIU Ruili, LI Lanjun, JIA Minlei, WANG Yihui, HAO Weina. Correlation between tumor miR-7-5p and NOVA2 levels and clinical prognosis in cancer tissues of patients with gastric cancer [J]. Laboratory Medicine, 2023, 38(4): 325-329. |
[11] | YUAN Shuang, FENG Lei, GUO Xiaofen, FU Xiaoling, XU Jing, LIU Hongyang. Relation of miR-433 in endometrial cancer tissues and its relationship with chemotherapy sensitivity [J]. Laboratory Medicine, 2023, 38(4): 337-341. |
[12] | CHEN Zhe, ZHANG Ling, LIU Jie, WANG Xia, ZHANG Bin, GAO Binghua. Relationship between serum miR-326 and chemotherapy sensitivity and prognosis in patients with treatment-related hematological malignancy [J]. Laboratory Medicine, 2023, 38(3): 251-256. |
[13] | LIU Chong, ZHANG Jing, LI Sheng, ZHAO Qi. Expressions and correlation of miR-335 and Fra-1 in breast cancer [J]. Laboratory Medicine, 2023, 38(2): 143-147. |
[14] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[15] | GAO Jianchao, WANG Sisi, ZHANG Zhisheng, ZHANG Jingli, LI Xiaoxia, MA Ke, FENG Zhilin, ZHOU Haifeng, WANG Zhanhai. Efficacy and prognosis evaluation of neo-adjuvant chemotherapy for breast cancer based on miR-206,miR-125 and miR-21 [J]. Laboratory Medicine, 2023, 38(11): 1062-1068. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||